Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
About This Item
UNSPSC Code:
12352203
NACRES:
NA.46
eCl@ss:
32160702
biological source
rabbit
conjugate
TRITC conjugate, rhodamine conjugate
antibody form
F(ab′)2 fragment of affinity isolated antibody
antibody product type
secondary antibodies
clone
polyclonal
species reactivity
goat
manufacturer/tradename
Chemicon®
concentration
1.5 mg/mL
technique(s)
immunofluorescence: suitable
shipped in
wet ice
target post-translational modification
unmodified
Application
Research Category
Secondary & Control Antibodies
Secondary & Control Antibodies
Research Sub Category
Whole Immunoglobulin Secondary Antibodies
Whole Immunoglobulin Secondary Antibodies
Suggested dilution for most applications: 1:50-1:200 for most applications.Optimal working dilutions must be determined by the end user.
This Rabbit anti-Goat IgG Antibody, Rhodamine conjugate is validated for use in IF for the detection of Goat IgG.
Biochem/physiol Actions
Goat IgG (H+L)
FLUOROPHORE/PROTEIN ABSORBANCE RATIO
Tetramethyl Rhodamine Isothiocyanate A550/A280 = 0.46
The antibody is isolated from antisera by immunoaffinity chromatography using antigen coupled to agarose beads. No antibody was detected against non-immunoglobulin serum proteins by ELISA, antibodies may react with immunoglobulines from some other species.
FLUOROPHORE/PROTEIN ABSORBANCE RATIO
Tetramethyl Rhodamine Isothiocyanate A550/A280 = 0.46
The antibody is isolated from antisera by immunoaffinity chromatography using antigen coupled to agarose beads. No antibody was detected against non-immunoglobulin serum proteins by ELISA, antibodies may react with immunoglobulines from some other species.
Physical form
Lyophilized. Buffer = 0.01 M Sodium Phosphate, 0.25 M NaCl, pH 7.6 with 15 mg/mL BSA, 0.01% Thimerosal and 0.05% Sodium Azide.
RECONSTITUTION:
Reconstitute to 1 mg/mL with 1.5mL sterile distilled water.
RECONSTITUTION:
Reconstitute to 1 mg/mL with 1.5mL sterile distilled water.
Preparation Note
Maintain lyophilized product at 2-8°C for up to 12 months. After reconstitution the product is stable for several weeks at 2-8°C as an undiluted liquid. For extended storage after reconstitution, add an equal volume of glycerol to make a final concentration of 50% glycerol followed by storage at -20°C in undiluted aliquots for up to 12 months. Please note the concentration of protein (and buffer salts) will decrease to one-half of the original after the addition of glycerol. Avoid repeated freeze/thaw cycles.
Legal Information
CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany
Disclaimer
Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
Still not finding the right product?
Try our Product Selector Tool to narrow your options
signalword
Warning
hcodes
Hazard Classifications
Acute Tox. 4 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral - Aquatic Chronic 3
Storage Class
11 - Combustible Solids
wgk
WGK 3
Certificates of Analysis (COA)
Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Related Content
Evidence for phenotypic plasticity in aggressive triple-negative breast cancer: human biology is recapitulated by a novel model system.
D'Amato, NC; Ostrander, JH; Bowie, ML; Sistrunk, C; Borowsky, A; Cardiff, RD; Bell et al.
Testing null
Hsiao-Ming Chao et al.
Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 29(6), 539-549 (2013-03-30)
Retinal ischemia-associated ocular disorders are vision threatening. This study examined whether the flavonoid baicalein is able to protect against retinal ischemia/reperfusion. Using rats, the intraocular pressure was raised to 120 mmHg for 60 min to induce retinal ischemia. In vitro
Xiao-Qian Liu et al.
Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 29(1), 33-40 (2012-10-19)
Retinal ischemia-associated ocular disorders, such as retinal occlusive disorders, neovascular age-related macular degeneration, proliferative diabetic retinopathy, and glaucoma are vision-threatening. In this study, we examined whether and by what mechanisms resveratrol, a polyphenol found in red wine, is able to
